The DOI matches its Crossref record.
Clinical proteomics: Written in blood
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Self-citationPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Self-citationADAMs: key components in EGFR signalling and development
Blobel, C. P. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1548 · Cited by 1,090
Anderson, N. L., Polanski, M., Pieper, R., Gatlin, T., Tirumalai, R. S., Conrads, T. P., Veenstra, T. D., Adkins, J. N., Pounds, J. G., Fagan, R., et al. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300127-mcp200 · Cited by 1,006
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
Kulasingam, V., & Diamandis, E. P. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1187 · Cited by 771
Weston, A. D., & Hood, L. (2004) · Journal of Proteome Research · doi:10.1021/pr0499693 · Cited by 731
Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool
Diamandis, E. P. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r400007-mcp200 · Cited by 631
(2020) · Elsevier eBooks · doi:10.1016/c2017-1-02257-2 · Cited by 491
Nanotechnologies for biomolecular detection and medical diagnostics
Cheng, M. M.-C., Cuda, G., Bunimovich, Y. L., Gaspari, M., Heath, J. R., Hill, H. D., Mirkin, C. A., Nijdam, A. J., Terracciano, R., Thundat, T., et al. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.01.006 · Cited by 474
Self-citationLiu, T., Qian, W.-J., Gritsenko, M. A., Camp, D. G., Monroe, M. E., Moore, R. J., & Smith, R. D. (2005) · Journal of Proteome Research · doi:10.1021/pr0502065 · Cited by 405
Adsorption and Immobilization of Cytochrome c on Nanodiamonds
Huang, L.-C. L., & Chang, H.-C. (2004) · Langmuir · doi:10.1021/la0495736 · Cited by 376
Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer
Kawasaki, E. S., & Player, A. (2005) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.03.002 · Cited by 368
Scoring proteomes with proteotypic peptide probes
Kuster, B., Schirle, M., Mallick, P., & Aebersold, R. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1683 · Cited by 364
The blood peptidome: a higher dimension of information content for cancer biomarker discovery
Petricoin, E. F., Belluco, C., Araujo, R. P., & Liotta, L. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2011 · Cited by 357
Self-citationSELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer
Petricoin, E. F., & Liotta, L. A. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.01.005 · Cited by 331
Self-citationUtilizing Human Blood Plasma for Proteomic Biomarker Discovery
Jacobs, J. M., Adkins, J. N., Qian, W.-J., Liu, T., Shen, Y., Camp, D. G., & Smith, R. D. (2005) · Journal of Proteome Research · doi:10.1021/pr0500657 · Cited by 316
Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor Microenvironment
Celis, J. E., Gromov, P., Cabezón, T., Moreira, J. M. A., Ambartsumian, N., Sandelin, K., Rank, F., & Gromova, I. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400009-mcp200 · Cited by 305
Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers
Caldorera-Moore, M., Guimard, N., Shi, L., & Roy, K. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903579971 · Cited by 304
Discovery of Protein Biomarkers for Renal Diseases
Hewitt, S. M., Dear, J., & Star, R. A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000129114.92265.32 · Cited by 295
A Theoretical Model for the Margination of Particles within Blood Vessels
Decuzzi, P., Lee, S., Bhushan, B., & Ferrari, M. (2005) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-8976-5 · Cited by 280
Self-citationDetection of cancer biomarkers in serum using a hybrid mechanical and optoplasmonic nanosensor
Kosaka, P. M., Pini, V., Ruz, J. J., da Silva, R. A., González, M. U., Ramos, D., Calleja, M., & Tamayo, J. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.250 · Cited by 278
High-resolution serum proteomic features for ovarian cancer detection.
Conrads, T. P., Fusaro, V. A., Ross, S., Johann, D., Rajapakse, V, Hitt, B. A., Steinberg, S. M., Kohn, E. C., Fishman, D. A., Whitely, G., et al. (2004) · Endocrine-related cancer · doi:10.1677/erc.0.0110163 · Cited by 260
Self-citationThe Need for a Transdisciplinary, Global Health Framework
Picard, M., Sabiston, C. M., & McNamara, J. K. (2011) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2010.0149 · Cited by 28
Cunningham, S., O’Doherty, K. C., Sénécal, K., Secko, D., & Avard, D. (2015) · Journal of Community Genetics · doi:10.1007/s12687-014-0206-0 · Cited by 21
Metadata
- Authors
- Liotta, L. A., Ferrari, M., & Petricoin, E.
- Venue
- Nature
- Published
- 2003-10-30
- Volume
- 425
- Issue
- 6961
- Pages
- 905-905
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2043256631
- Cited by
- 534
- References
- 0
- FWCI
- 19.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.